B. Braun Launches First Ever Emergency Department-Specific Nerve Block Tray

BETHLEHEM, Pa., Feb. 18, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), the U.S. market leader in regional anesthesia (RA), announced today the launch of the Emergency Department Single-Shot Nerve Block Tray to the U.S. market.¹ The tray is specifically designed for emergency departments and supports clinicians in providing safe, effective pain management while reducing opioid use and its complications in acute care settings.² Featuring advanced echogenic technology for improved ultrasound visibility, it is the first ever peripheral nerve block (PNB) tray to include our Ultraplex^® 360 Needle, which is preferred by 91% of clinicians over competing options.³

The tray is equipped with essential components for single-shot nerve block procedures, enabling emergency department clinicians to perform precise nerve blocks quickly and effectively. The Ultraplex 360 Needle features B. Braun's echogenic 360° X-pattern which, when combined with a clear coating, is intended to reflect more ultrasound waves back to the probe than previous designs.⁴ This needle is designed to provide visibility without compromising consistent puncture performance.¹

In the emergency department, regional anesthesia offers a safe and effective alternative to opioid therapies, improves patient satisfaction and reduces pain scores.² It also helps reduce the transition of acute to chronic pain, reduces length of stay and lowers in-hospital cost.⁵

"Our goal is to improve outcomes in the emergency department with regional anesthesia: a safe and effective alternative to opioid therapies that improve patient satisfaction," said Peter McGregor, Director of Marketing, Pain Control. "This tray exemplifies our commitment to continuously developing innovative solutions for clinicians and patients."

Learn more about our Emergency Department Single-Shot Nerve Block Tray at bbraunusa.com.

About B. Braun

B. Braun Medical Inc. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we're uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap^® and CAPS^®. The company employs 8,500 people at over 30 locations across North America.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise^® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website. 

References

1. IMS Data Q4 2020
2. Goldsmith, A., Driver, L., Duggan, N. M., Riscinti, M., Martin, D., Heffler, M., Shokoohi, H., Dreyfuss, A., Sell, J., Brown, C., Fung, C., Perice, L., Bennett, D., Truong, N., Jafry, S. Z., Macias, M., Brown, J., & Nagdev, A. (2024). Complication Rates After Ultrasonography-Guided Nerve Blocks Performed in the Emergency Department. JAMA Network Open, 7(11), e2444742. https://doi.org/10.1001/jamanetworkopen.2024.44742
3. Cooper D, van Geffen GJ, Bruaset I, et al. Regional block needles: a matter of feel and brightness. Poster presented at 35th Annual European Society of Regional Anaesthesia Congress September 7-10, 2016; Maastricht, Limburg, Netherlands.
4. Engineering Test Report NPAK-A8TP1B
5. Cogan, C. J., & Kandemir, U. (2020). Role of peripheral nerve block in pain control for the management of acute traumatic orthopaedic injuries in the emergency department: Diagnosis-based treatment guidelines. Injury, 51(7), 1422–1425. https://doi.org/10.1016/j.injury.2020.04.016

SOURCE B. Braun Medical Inc.